Skip to main content
. 2020 May 12;4(9):2111–2118. doi: 10.1182/bloodadvances.2019000849

Figure 1.

Figure 1.

Comparison of traditional and novel hemophilia therapies. Similarities and differences of hemophilia A treatment between FVIII replacement therapy, emicizumab, fitusiran, and anti-TFPI antibodies with regard to patient target group, mode of administration, and therapeutic levels over time.